Nephrology Topic

The contrast nephropathy myth.

Most AKI blamed on CT contrast was never caused by it. The confounding behind the myth, why PRESERVE and AMACING ended NAC and bicarbonate prophylaxis, and the narrow group where caution still applies.

Reviewed June 2026 · verify against current guidelines

Where The Fear Came From

Blame by association.

The old teaching

For decades, any creatinine bump after contrast was labeled contrast-induced nephropathy. Scans were delayed or withheld to avoid it.

The flaw

The early studies had no control group, and the patients getting contrast were sicker. Their AKI got pinned on the dye, not on the illness that put them in the scanner.

What the myth cost

Delayed or cancelled CT for PE, stroke, and dissection.
Reflexive N-acetylcysteine, bicarbonate, and saline of no benefit.

No uncontrolled study can separate the dye from the disease that prompted the scan.

Correlation vs Cause

Match the patients.

ACR-NKF terminology

CA-AKI	Contrast-associated: any AKI within 48 h of contrast. Correlation only.
CI-AKI	Contrast-induced: AKI actually caused by the dye. Far rarer.

Add a control group

Meta-analysis: 21 matched cohorts, 169,455 patients. No excess AKI, dialysis, or death at eGFR ≥45.
Hinson: 17,934 ER patients, contrast CT vs unenhanced vs no CT. Same AKI rates.

Propensity matching pairs contrast and no-contrast patients with the same risk profile, isolating the dye's true effect.

Matched against controls, IV contrast did not independently raise AKI.

CA-AKI contrast-associated AKICI-AKI contrast-induced AKIeGFR estimated GFRACR-NKF American College of Radiology + National Kidney Foundation

What Doesn't Help

Stop the rituals.

Prophylaxis trials

PRESERVE (2018)	5,177 high-risk angiography patients. IV bicarbonate vs saline, NAC vs placebo. No benefit on death, dialysis, or renal decline.
AMACING (2017)	High-risk patients. No prophylaxis vs IV saline. Non-inferior; IV hydration itself caused complications in 5.5%.

Bottom line

N-acetylcysteine, bicarbonate, fenoldopam, and renal-dose dopamine are all out. Even routine saline is now questioned outside the highest-risk patients.

Prophylaxis has its own harms. Fluid overload is not free.

NAC N-acetylcysteineIV intravenous

When To Still Take Care

Caution, not paralysis.

Still warrants care

eGFR <30 or AKI	The one group with real, if small, risk. Consider IV isotonic saline. Skip NAC and bicarbonate.
Intra-arterial	Cardiac cath (first-pass renal dose) carries more risk than IV CT contrast.

Metformin (ACR 2025)

eGFR ≥30, no AKI	Continue. No need to hold.
eGFR <30 or AKI	Hold at the procedure, restart after 48 h if renal function is stable.

Solitary kidney is not an independent risk factor (ACR-NKF). Judge by eGFR.

Never delay emergent contrast CT (stroke, PE, dissection) over nephropathy fear.

eGFR estimated GFRAKI acute kidney injuryNAC N-acetylcysteineACR American College of Radiology

Sources

Verify against current guidelines and local protocol before acting.

Davenport MS et al. Use of IV Iodinated Contrast Media in Patients with Kidney Disease: ACR-NKF Consensus Statements. Radiology 2020;294:660-668.
Weisbord SD et al. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine (PRESERVE). NEJM 2018;378:603-614.
Nijssen EC et al. Prophylactic hydration to protect renal function (AMACING). Lancet 2017;389:1312-1322.
Hinson JS et al. Risk of AKI After IV Contrast Media Administration. Ann Emerg Med 2017;69:577-586.
Risk of AKI after contrast-enhanced CT: systematic review and meta-analysis of 21 propensity-matched cohorts (169,455 patients). Eur Radiol 2022.
ACR Manual on Contrast Media, 2025 edition.

Downloads

Every card for this topic — carousels and tables, print-ready for the wards or for sharing.

Carousel6 slides